Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Imagion Biosystems

Tracked across 1 events · 6 articles · First seen Jun 09, 2026 · Last active Jun 30, 2026

Sentiment
75
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 75
Business
Impact: Imagion Biosystems secured AU$3.75 million in new capital, which will fund the commencement of a Phase 2 clinical trial for its MagSense imaging agent in HER2-positive breast cancer. This funding is crucial for advancing its molecular MRI technology.
Jun 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Imagion Biosystems live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.